OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CRISPR screens decode cancer cell pathways that trigger γδ T cell detection
Murad R. Mamedov, Shane Vedova, Jacob W. Freimer, et al.
Nature (2023) Vol. 621, Iss. 7977, pp. 188-195
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

The B7:CD28 family and friends: Unraveling coinhibitory interactions
Kelly P. Burke, Apoorvi Chaudhri, Gordon J. Freeman, et al.
Immunity (2024) Vol. 57, Iss. 2, pp. 223-244
Open Access | Times Cited: 30

Structural characterization of two γδ TCR/CD3 complexes
Mohammed Hoque, John Benji Grigg, Trudy F. Ramlall, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2

CRISPR–Cas9 applications in T cells and adoptive T cell therapies
Xiaoying Chen, Shuhan Zhong, Yonghao Zhan, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 15

Immune mechanisms in the pathophysiology of hypertension
Bianca Nguyen, Matthew R. Alexander, David G. Harrison
Nature Reviews Nephrology (2024) Vol. 20, Iss. 8, pp. 530-540
Closed Access | Times Cited: 11

Payload-delivering engineered γδ T cells display enhanced cytotoxicity, persistence, and efficacy in preclinical models of osteosarcoma
Daniel Fowler, Marta Barisa, Alba Southern, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 749
Open Access | Times Cited: 10

γδ T cells as critical anti-tumor immune effectors
Marcel Arias-Badia, R. Shihman Chang, Lawrence Fong
Nature Cancer (2024) Vol. 5, Iss. 8, pp. 1145-1157
Closed Access | Times Cited: 9

Cancer immunotherapy by γδ T cells
Adrian Hayday, Julie Déchanet‐Merville, Jamie Rossjohn, et al.
Science (2024) Vol. 386, Iss. 6717
Open Access | Times Cited: 9

Unsynchronized butyrophilin molecules dictate cancer cell evasion of Vγ9Vδ2 T-cell killing
Zeguang Wu, Qiezhong Lamao, Meichao Gu, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 4, pp. 362-373
Closed Access | Times Cited: 8

Tumor-infiltrating T lymphocytes: A promising immunotherapeutic target for preventing immune escape in cholangiocarcinoma
Sijia Hua, Xinyi Gu, Hangbin Jin, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117080-117080
Open Access | Times Cited: 8

Phosphoantigen recognition by Vγ9Vδ2 T cells
Thomas Herrmann, Mohindar Murugesh Karunakaran
European Journal of Immunology (2024) Vol. 54, Iss. 11
Open Access | Times Cited: 8

The present and future of the Cancer Dependency Map
Rand Arafeh, Tsukasa Shibue, Joshua M. Dempster, et al.
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 7

When DNA damage responses meet tumor immunity: From mechanism to therapeutic opportunity
Dong Pan, Qi Wang, AiHua Shen, et al.
International Journal of Cancer (2024) Vol. 155, Iss. 3, pp. 384-399
Closed Access | Times Cited: 5

Immune Regulatory Networks and Therapy of γδ T Cells in Liver Cancer: Recent Trends and Advancements
Kun-Li Yin, Kai-Jian Chu, Ming O. Li, et al.
Journal of Clinical and Translational Hepatology (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 4

Shaping immunity: The influence of natural selection on population immune diversity
Haley E. Randolph, Katherine A Aracena, Yen‐Lung Lin, et al.
Immunological Reviews (2024) Vol. 323, Iss. 1, pp. 227-240
Open Access | Times Cited: 4

CRISPR in Targeted Therapy and Adoptive T Cell Immunotherapy for Hepatocellular Carcinoma
Fahreddin Palaz, Mehmet Özsöz, Ali Zarrinpar, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 975-995
Open Access | Times Cited: 4

Evolutionary trajectories of immune escape across cancers
Wen-Jie Chen, Toby M. Baker, Zhihui Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Prognostic implications of PCSK9 expression in HER2-positive breast cancer
Zongwen Wu, D. Wu, Chengsheng Huang, et al.
ONCOLOGIE (2025)
Closed Access

Unusual Partners: γδ-TCR-Based T Cell Therapy in Combination with Oncolytic Virus Treatment for Diffuse Midline Gliomas
Konstantinos Vazaios, Patricia Hernández López, Tineke Aarts‐Riemens, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2167-2167
Open Access

γδ T cells and head and neck squamous cell carcinoma
Jiayu Peng, Huibin Qiu, Lin‐Lin Bu, et al.
International review of cell and molecular biology (2025)
Closed Access

Mapping the extracellular molecular architecture of the pAg-signaling complex with α-Butyrophilin antibodies
Amrita Ramesh, Sobhan Roy, Tomasz Ślężak, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Human γδ T Cell Function Is Impaired Upon Mevalonate Pathway Inhibition
Tsz Kin Suen, Burcu Al, Thomas Ulas, et al.
Immunology (2025)
Open Access

γδ T cells as a potential therapeutic agent for glioblastoma
In Kang, Yumin Kim, Heung Kyu Lee
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9

Page 1 - Next Page

Scroll to top